PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ChemRar High-Tech Center, 141401 Moscow, Russia.\', \'IPHARMA LLC, Skolkovo Innovative Centre, 121205 Moscow, Russia.\', \'ChemRar Research Institute, 141401 Moscow, Russia.\', \'Chemical Diversity Research Institute, 141401 Moscow, Russia.\', \'JSC \'Special Economic Zones\', 125009 Moscow, Russia.\', \'Centre for Strategic Planning of the Federal Medical-Biological Agency (FMBA), 119121 Moscow, Russia.\', \'Clinical Hospital No. 1, 214006 Smolensk, Russia.\', \'ChemDiv Inc., San Diego, CA 92121-3103, USA.\', \'Chromis LLC, Skolkovo Innovative Centre, 121205 Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 125310.3390/v13071253
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34199134
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34199134>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34199134>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all